THOMAS PAUL

Track

Insider profile

Performance

Overall performance
1.3
Performance over holding periods
1.3
30 days 90 days 120 days
Average return -13% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
THOMAS PAUL's trades of AxoGen, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
209.65
Quantity 90,636 +23.2%
Value US$362,400
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
314.47
Quantity 68,165
Value US$2,214,960
US ABIOMED Inc (ABMD)
Transaction date
Planned sale
Price
190.19
Quantity 92,515 +22.3%
Value US$836,370
US ABIOMED Inc (ABMD)
Transaction date
Planned sale
Price
303.41
Quantity 2,000 -23.4%
Value US$606,820
US ABIOMED Inc (ABMD)
Transaction date
Planned sale
Price
151.78
Quantity 2,000 -18.3%
Value US$303,561
US ABIOMED Inc (ABMD)
Transaction date
Planned sale
Price
181.13
Quantity 2,000 -15.5%
Value US$362,250
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-10 2025-12-09
US AxoGen, Inc. (AXGN)
S Sale
90,636 +23.2%
209.65
US$362,400 		90,636 +23.2% 209.65 US$362,400
2025-12-09 2025-12-09
US AxoGen, Inc. (AXGN)
PrS Proposed sale
68,165
314.47
US$2,214,960 		68,165 314.47 US$2,214,960
2022-11-03 2022-11-01
US ABIOMED Inc (ABMD)
PlS Planned sale
92,515 +22.3%
190.19
US$836,370 		92,515 +22.3% 190.19 US$836,370
2020-08-11 2020-08-10
US ABIOMED Inc (ABMD)
PlS Planned sale
2,000 -23.4%
303.41
US$606,820 		2,000 -23.4% 303.41 US$606,820
2020-03-04 2020-03-02
US ABIOMED Inc (ABMD)
PlS Planned sale
2,000 -18.3%
151.78
US$303,561 		2,000 -18.3% 151.78 US$303,561
2020-02-12 2020-02-10
US ABIOMED Inc (ABMD)
PlS Planned sale
2,000 -15.5%
181.13
US$362,250 		2,000 -15.5% 181.13 US$362,250